{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:38:02Z","timestamp":1786451882798,"version":"build-2736575974"},"reference-count":85,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"unspecified","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","award":["90000803"],"award-info":[{"award-number":["90000803"]}],"id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,7,25]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Viral respiratory infections are highly contagious and associated with an increased risk of serious adverse health outcomes in vulnerable populations, including people with intellectual disabilities. However, little is known about the overall disease burden of viral respiratory infections among people with intellectual disabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This scoping review aims to provide an overview of the existing literature on the disease burden of viral respiratory infections among people with intellectual disabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Studies published between 1999 and 10 July 2024, were identified through PubMed, MEDLINE, Embase and Web of Science, and included if focused on adults with intellectual disabilities, viral respiratory infections and relevant health outcomes such as infection rate, mortality, hospitalisation, functional impairments or quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>58 articles were included, of which the majority focused on COVID-19 (42\/58) or influenza (13\/58). Studies varied in their methodology and outcome measures. Evidence on COVID-19 and influenza showed that people with intellectual disabilities experience a higher disease burden from these infections compared with the general population. Particularly disproportionate effects were evident among people with Down syndrome, who had higher mortality estimates and an increased burden of comorbidities associated with severe disease and death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although available evidence appeared limited and diverse, this scoping review shows a higher disease burden in people with intellectual disabilities, in particular for COVID-19 and influenza-type viruses, which can be indicative of the impact of other viral respiratory infections as well. This highlights the importance of measures to prevent and control the spread of respiratory pathogens among this group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-004082","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:06:13Z","timestamp":1786449973000},"page":"e004082","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Disease burden of viral respiratory infections in people with intellectual disabilities: a scoping review"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7566-5021","authenticated-orcid":false,"given":"Lynette J","family":"van Susante-Oost","sequence":"first","affiliation":[{"name":"Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Academic Collaborative Intellectual Disability and Health, Sterker op Eigen Benen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Mastebroek","sequence":"additional","affiliation":[{"name":"Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Academic Collaborative Intellectual Disability and Health, Sterker op Eigen Benen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique C J","family":"Koks-Leensen","sequence":"additional","affiliation":[{"name":"Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Academic Collaborative Intellectual Disability and Health, Sterker op Eigen Benen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aura","family":"Timen","sequence":"additional","affiliation":[{"name":"Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraline L","family":"Leusink","sequence":"additional","affiliation":[{"name":"Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Academic Collaborative Intellectual Disability and Health, Sterker op Eigen Benen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1715-4375","authenticated-orcid":false,"given":"Maarten","family":"Cuypers","sequence":"additional","affiliation":[{"name":"Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Academic Collaborative Intellectual Disability and Health, Sterker op Eigen Benen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"2026081105052652000_13.1.e004082.1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(18)30310-4"},{"key":"2026081105052652000_13.1.e004082.2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104593","article-title":"Viral respiratory infections in a rapidly changing climate: the need to prepare for the next pandemic","volume":"93","author":"He","year":"2023","journal-title":"EBioMedicine"},{"key":"2026081105052652000_13.1.e004082.3","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25674"},{"key":"2026081105052652000_13.1.e004082.4","doi-asserted-by":"crossref","unstructured":"van Doorn HR , Yu H . Viral Respiratory Infections. Hunter\u2019s Tropical Medicine and Emerging Infectious Diseases 2020;284\u20138. doi:10.1016\/B978-0-323-55512-8.00033-8","DOI":"10.1016\/B978-0-323-55512-8.00033-8"},{"key":"2026081105052652000_13.1.e004082.5","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01248-7"},{"key":"2026081105052652000_13.1.e004082.6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/pubmed\/fdae178","article-title":"The effectiveness of interventions to reduce the transmission of acute respiratory infections in care homes: a systematic review","volume":"46","author":"Willcox","year":"2024","journal-title":"J Public Health (Bangkok)"},{"key":"2026081105052652000_13.1.e004082.7","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1922743"},{"key":"2026081105052652000_13.1.e004082.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2010.12.018"},{"key":"2026081105052652000_13.1.e004082.9","doi-asserted-by":"crossref","DOI":"10.1186\/s43058-024-00579-8","article-title":"Identifying barriers and facilitators to primary care practitioners implementing health assessments for people with intellectual disability: a Theoretical Domains Framework-informed scoping review","volume":"5","author":"Caltabiano","year":"2024","journal-title":"Implement Sci Commun"},{"key":"2026081105052652000_13.1.e004082.10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621440","article-title":"Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome","volume":"12","author":"Illouz","year":"2021","journal-title":"Front Immunol"},{"key":"2026081105052652000_13.1.e004082.11","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2026081105052652000_13.1.e004082.12","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"2026081105052652000_13.1.e004082.13","doi-asserted-by":"crossref","unstructured":"Moola S , Munn Z , Tufanaru C , et al . Systematic reviews of etiology and risk (2020): JBI manual for evidence synthesis. JBI, 2024.","DOI":"10.46658\/JBIMES-24-06"},{"key":"2026081105052652000_13.1.e004082.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052482","article-title":"Understanding inequalities in COVID-19 outcomes following hospital admission for people with intellectual disability compared to the general population: a matched cohort study in the UK","volume":"11","author":"Baksh","year":"2021","journal-title":"BMJ Open"},{"key":"2026081105052652000_13.1.e004082.15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/ciac826","article-title":"Severity of Coronavirus Disease 2019 Hospitalization Outcomes and Patient Disposition Differ by Disability Status and Disability Type","volume":"76","author":"Clarke","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026081105052652000_13.1.e004082.16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3201\/eid2901.221346","article-title":"Risk for Severe COVID-19 Outcomes among Persons with Intellectual Disabilities, the Netherlands","volume":"29","author":"Koks-Leensen","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"2026081105052652000_13.1.e004082.17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijid.2022.01.038","article-title":"Severe Outcomes, Readmission, and Length of Stay Among COVID-19 Patients with Intellectual and Developmental Disabilities","volume":"116","author":"Koyama","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2026081105052652000_13.1.e004082.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-03216-8","article-title":"Post-COVID-19 condition risk in patients with intellectual and developmental disabilities: a retrospective cohort study involving 36,308 patients","volume":"21","author":"Liu","year":"2023","journal-title":"BMC Med"},{"key":"2026081105052652000_13.1.e004082.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-023-16993-x","article-title":"Understanding covid-19 outcomes among people with intellectual disabilities in England","volume":"23","author":"Sosenko","year":"2023","journal-title":"BMC Public Health"},{"key":"2026081105052652000_13.1.e004082.20","doi-asserted-by":"crossref","first-page":"100942","DOI":"10.1016\/j.dhjo.2020.100942","article-title":"Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis","volume":"13","author":"Turk","year":"2020","journal-title":"Disabil Health J"},{"key":"2026081105052652000_13.1.e004082.21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/jir.13116","article-title":"Hospitalisation and mortality among privately insured individuals with COVID-19 in the United States: The role of intellectual disabilities and Neurogenetic disorders","volume":"68","author":"Davis","year":"2024","journal-title":"J Intellect Disabil Res"},{"key":"2026081105052652000_13.1.e004082.22","doi-asserted-by":"crossref","first-page":"101623","DOI":"10.1016\/j.dhjo.2024.101623","article-title":"Covid-19 patterns among adults with intellectual and developmental disability and the general population in New York state during the first year of the pandemic","volume":"17","author":"Formica","year":"2024","journal-title":"Disabil Health J"},{"key":"2026081105052652000_13.1.e004082.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-022-07121-y","article-title":"Linked nosocomial COVID-19 outbreak in three facilities for people with intellectual and developmental disabilities due to SARS-CoV-2 variant B.1.1.519 with spike mutation T478K in the Netherlands","volume":"22","author":"Gorgels","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2026081105052652000_13.1.e004082.24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.12862","article-title":"Risk Factors Associated With COVID-19 Outcomes Among People With Intellectual and Developmental Disabilities Receiving Residential Services","volume":"4","author":"Landes","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026081105052652000_13.1.e004082.25","doi-asserted-by":"crossref","first-page":"101645","DOI":"10.1016\/j.dhjo.2024.101645","article-title":"Predictors of COVID-19 infection and hospitalization in group homes for individuals with intellectual and\/or developmental disabilities","volume":"17","author":"Levison","year":"2024","journal-title":"Disabil Health J"},{"key":"2026081105052652000_13.1.e004082.26","first-page":"1","article-title":"Factors associated with COVID-19 infections among a high-risk sample of adults with intellectual and developmental disabilities in Ontario","volume":"27","author":"Hansford","year":"2022","journal-title":"J Dev Disabl"},{"key":"2026081105052652000_13.1.e004082.27","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2021-218192"},{"key":"2026081105052652000_13.1.e004082.28","doi-asserted-by":"crossref","first-page":"101174","DOI":"10.1016\/j.dhjo.2021.101174","article-title":"COVID-19 positivity rates, hospitalizations and mortality of adults with and without intellectual and developmental disabilities in Ontario, Canada","volume":"15","author":"Lunsky","year":"2022","journal-title":"Disabil Health J"},{"key":"2026081105052652000_13.1.e004082.29","doi-asserted-by":"crossref","first-page":"101376","DOI":"10.1016\/j.dhjo.2022.101376","article-title":"COVID-19 mortality burden and comorbidity patterns among decedents with and without intellectual and developmental disability in the US","volume":"15","author":"Landes","year":"2022","journal-title":"Disabil Health J"},{"key":"2026081105052652000_13.1.e004082.30","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1016\/S2468-2667(23)00062-2","article-title":"All-cause and cause-specific mortality among people with and without intellectual disabilities during the COVID-19 pandemic in the Netherlands: a population-based cohort study","volume":"8","author":"Cuypers","year":"2023","journal-title":"Lancet Public Health"},{"key":"2026081105052652000_13.1.e004082.31","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S2468-2667(23)00079-8","article-title":"Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform","volume":"8","author":"Nab","year":"2023","journal-title":"Lancet Public Health"},{"key":"2026081105052652000_13.1.e004082.32","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-01949-4","article-title":"Paradoxical low severity of COVID-19 in Prader-Willi syndrome: data from a French survey on 647 patients","volume":"16","author":"Coupaye","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2026081105052652000_13.1.e004082.33","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2021.100228","article-title":"All-cause and cause-specific mortality in people with mental disorders and intellectual disabilities, before and during the COVID-19 pandemic: cohort study","volume":"11","author":"Das-Munshi","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"2026081105052652000_13.1.e004082.34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bld.12578","article-title":"Health and healthcare of people with learning disabilities in the United Kingdom through the COVID\u201019 pandemic","volume":"52","author":"Hatton","year":"2024","journal-title":"Brit J Learn Disabil"},{"key":"2026081105052652000_13.1.e004082.35","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/jar.12914","article-title":"Deaths of people with intellectual disabilities: Analysis of deaths in England from COVID-19 and other causes","volume":"34","author":"Heslop","year":"2021","journal-title":"J Appl Res Intellect Disabil"},{"key":"2026081105052652000_13.1.e004082.36","doi-asserted-by":"crossref","first-page":"101116","DOI":"10.1016\/j.dhjo.2021.101116","article-title":"COVID-19 case-fatality disparities among people with intellectual and developmental disabilities: Evidence from 12 US jurisdictions","volume":"14","author":"Landes","year":"2021","journal-title":"Disabil Health J"},{"key":"2026081105052652000_13.1.e004082.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2020.100969"},{"key":"2026081105052652000_13.1.e004082.38","doi-asserted-by":"crossref","first-page":"101051","DOI":"10.1016\/j.dhjo.2020.101051","article-title":"COVID-19 outcomes among people with intellectual and developmental disability in California: The importance of type of residence and skilled nursing care needs","volume":"14","author":"Landes","year":"2021","journal-title":"Disabil Health J"},{"key":"2026081105052652000_13.1.e004082.39","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/appi.ps.202000620","article-title":"COVID-19 in a New York City Behavioral Health Housing and Treatment System","volume":"72","author":"Tse","year":"2021","journal-title":"PS"},{"key":"2026081105052652000_13.1.e004082.40","doi-asserted-by":"crossref","first-page":"668214","DOI":"10.3389\/fpubh.2021.668214","article-title":"Applying Genomic Epidemiology to Characterize a COVID-19 Outbreak in a Developmentally Disabled Adult Group Home Setting, Arizona","volume":"9","author":"Yaglom","year":"2021","journal-title":"Front Public Health"},{"key":"2026081105052652000_13.1.e004082.41","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n1592","article-title":"Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform","volume":"374","author":"Williamson","year":"2021","journal-title":"BMJ"},{"key":"2026081105052652000_13.1.e004082.42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/infdis\/jiac236","article-title":"Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System","volume":"226","author":"Ku","year":"2022","journal-title":"J Infect Dis"},{"key":"2026081105052652000_13.1.e004082.43","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s11606-022-07420-9","article-title":"Susceptibility to COVID-19 Diagnosis in People with Down Syndrome Compared to the General Population: Matched-Cohort Study Using Primary Care Electronic Records in the UK","volume":"37","author":"Baksh","year":"2022","journal-title":"J Gen Intern Med"},{"key":"2026081105052652000_13.1.e004082.44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12017-021-08651-5","article-title":"Specific Susceptibility to COVID-19 in Adults with Down Syndrome","volume":"23","author":"Illouz","year":"2021","journal-title":"Neuromol Med"},{"key":"2026081105052652000_13.1.e004082.45","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.3390\/jcm10163748","article-title":"Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome","volume":"10","author":"Real de Asua","year":"2021","journal-title":"JCM"},{"key":"2026081105052652000_13.1.e004082.46","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05091-8"},{"key":"2026081105052652000_13.1.e004082.47","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100769","article-title":"Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey","volume":"33","author":"H\u00fcls","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026081105052652000_13.1.e004082.48","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/ajmg.a.61867","article-title":"Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series","volume":"182","author":"Villani","year":"2020","journal-title":"Am J Med Genet A"},{"key":"2026081105052652000_13.1.e004082.49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/13668250.2024.2317792","article-title":"COVID-19 in patients with Down syndrome: Characteristics of hospitalisation and disease progression compared to patients without Down syndrome","volume":"49","author":"Hofmann","year":"2024","journal-title":"J Intellect Dev Disabil"},{"key":"2026081105052652000_13.1.e004082.50","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41436-020-01004-w","article-title":"Individuals with Down syndrome hospitalized with COVID-19 have more severe disease","volume":"23","author":"Malle","year":"2021","journal-title":"Genet Med"},{"key":"2026081105052652000_13.1.e004082.51","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00439-022-02468-3","article-title":"Clinical characteristics and comorbidities of COVID-19 in unvaccinated patients with Down syndrome: first year report in Brazil","volume":"141","author":"Boschiero","year":"2022","journal-title":"Hum Genet"},{"key":"2026081105052652000_13.1.e004082.52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7326\/M20-4986","article-title":"COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults","volume":"174","author":"Clift","year":"2021","journal-title":"Ann Intern Med"},{"key":"2026081105052652000_13.1.e004082.53","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2021.100158","article-title":"Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people","volume":"8","author":"Semenzato","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"2026081105052652000_13.1.e004082.54","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.12.05035","article-title":"Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey","volume":"12","author":"Pinku","year":"2022","journal-title":"J Glob Health"},{"key":"2026081105052652000_13.1.e004082.55","doi-asserted-by":"publisher","DOI":"10.17294\/2330-0698.1824"},{"key":"2026081105052652000_13.1.e004082.56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.17294\/2330-0698.1876","article-title":"Prevalence of Infectious Diseases Among 6078 Individuals With Down Syndrome in the United States","volume":"9","author":"Fitzpatrick","year":"2022","journal-title":"J Patient Cent Res Rev"},{"key":"2026081105052652000_13.1.e004082.57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jir.12790","article-title":"Cause of death in adults with intellectual disability in the United States","volume":"65","author":"Landes","year":"2021","journal-title":"J Intellect Disabil Res"},{"key":"2026081105052652000_13.1.e004082.58","doi-asserted-by":"crossref","first-page":"100947","DOI":"10.1016\/j.dhjo.2020.100947","article-title":"Cause of death in adults with Down syndrome in the United States","volume":"13","author":"Landes","year":"2020","journal-title":"Disabil Health J"},{"key":"2026081105052652000_13.1.e004082.59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jir.12739","article-title":"Mortality of people with intellectual disabilities during the 2017\/2018 influenza epidemic in the Netherlands: potential implications for the COVID-19 pandemic","volume":"64","author":"Cuypers","year":"2020","journal-title":"J Intellect Disabil Res"},{"key":"2026081105052652000_13.1.e004082.60","doi-asserted-by":"publisher","DOI":"10.3201\/eid1608.091931"},{"key":"2026081105052652000_13.1.e004082.61","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2104"},{"key":"2026081105052652000_13.1.e004082.62","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12722"},{"key":"2026081105052652000_13.1.e004082.63","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/bld.12569","article-title":"Contributing causes of mortality and potentially avoidable deaths of people with intellectual or learning disability: A data\u2010linkage study","volume":"52","author":"Iffland","year":"2024","journal-title":"Brit J Learn Disabil"},{"key":"2026081105052652000_13.1.e004082.64","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12314"},{"key":"2026081105052652000_13.1.e004082.65","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020268","article-title":"Use of health services in the last year of life and cause of death in people with intellectual disability: a retrospective matched cohort study","volume":"8","author":"Brameld","year":"2018","journal-title":"BMJ Open"},{"key":"2026081105052652000_13.1.e004082.66","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1002\/ajmg.a.62355","article-title":"Pneumonia and respiratory infection in Down syndrome: A 10\u2010year cohort analysis of inpatient and outpatient encounters across the lifespan","volume":"185","author":"Blake","year":"2021","journal-title":"Am J Med Genet A"},{"key":"2026081105052652000_13.1.e004082.67","doi-asserted-by":"crossref","first-page":"318","DOI":"10.7883\/yoken.67.318","article-title":"Outbreak of Human Metapneumovirus Infection in a Severe Motor-and-Intellectual Disabilities Ward in Japan","volume":"67","author":"Yang","year":"2014","journal-title":"Jpn J Infect Dis"},{"key":"2026081105052652000_13.1.e004082.68","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1219","article-title":"COVID-19 in patients with Down syndrome: A systematic review","volume":"12","author":"Pitchan Velammal","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"2026081105052652000_13.1.e004082.69","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.61924"},{"key":"2026081105052652000_13.1.e004082.70","doi-asserted-by":"publisher","DOI":"10.1086\/382536"},{"key":"2026081105052652000_13.1.e004082.71","unstructured":"National Academies of Sciences E, and Medicine, Health and Medicine Division; Board on Health Sciences Policy, Committee on Best Practices for Assessing Mortality and Significant Morbidity Following Large-Scale Disasters . A framework for assessing mortality and morbidity after large-scale disasters. Washington (DC) National Academies Press (US) 2020; 2020."},{"key":"2026081105052652000_13.1.e004082.72","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1298595"},{"key":"2026081105052652000_13.1.e004082.73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.puhe.2021.04.002","article-title":"Linking national public services data to estimate the prevalence of intellectual disabilities in The Netherlands: results from an explorative population-based study","volume":"195","author":"Cuypers","year":"2021","journal-title":"Public Health"},{"key":"2026081105052652000_13.1.e004082.74","first-page":"303","article-title":"Research ethics and intellectual disability: broadening the debates","volume":"86","author":"Carlson","year":"2013","journal-title":"Yale J Biol Med"},{"key":"2026081105052652000_13.1.e004082.75","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.23889\/ijpds.v8i1.2151","article-title":"Overcoming ethical and legal obstacles to data linkage in health research: stakeholder perspectives","volume":"8","author":"Smit","year":"2023","journal-title":"IJPDS"},{"key":"2026081105052652000_13.1.e004082.76","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2468-2667(23)00057-9","article-title":"Multiple morbidity across the lifespan in people with Down syndrome or intellectual disabilities: a population-based cohort study using electronic health records","volume":"8","author":"Baksh","year":"2023","journal-title":"Lancet Public Health"},{"key":"2026081105052652000_13.1.e004082.77","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1352\/1944-7558-119.6.496","article-title":"Residential Transitions Among Adults With Intellectual Disability Across 20 Years","volume":"119","author":"Woodman","year":"2014","journal-title":"Am J Intellect Dev Disabil"},{"key":"2026081105052652000_13.1.e004082.78","unstructured":"Hodapp RM , Sanderson KA , Mello M . From transition through old age: caring for adults with down syndrome. In: Burack JA , Edgin JO , Abbeduto L , eds. The Oxford handbook of down syndrome and development. Oxford University Press, 2023."},{"key":"2026081105052652000_13.1.e004082.79","doi-asserted-by":"crossref","first-page":"1625179","DOI":"10.3389\/fmicb.2025.1625179","article-title":"Viral infection and thyroid disorders: a narrative review","volume":"16","author":"Li","year":"2025","journal-title":"Front Microbiol"},{"key":"2026081105052652000_13.1.e004082.80","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/EJE-21-1171","article-title":"The interplay of thyroid hormones and the immune system \u2013 where we stand and why we need to know about it","volume":"186","author":"Wenzek","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2026081105052652000_13.1.e004082.81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-021-00237-2","article-title":"COVID-19 and Alzheimer\u2019s disease: how one crisis worsens the other","volume":"10","author":"Xia","year":"2021","journal-title":"Transl Neurodegener"},{"key":"2026081105052652000_13.1.e004082.82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258701","article-title":"Barriers and facilitators to infection prevention and control in Dutch residential care facilities for people with intellectual and developmental disabilities: A theory-informed qualitative study","volume":"16","author":"Houben","year":"2021","journal-title":"PLoS One"},{"key":"2026081105052652000_13.1.e004082.83","doi-asserted-by":"crossref","first-page":"918","DOI":"10.17269\/s41997-022-00674-0","article-title":"Examining the development and utilization of infection control policies to safely support adults with intellectual and developmental disabilities in congregate living settings during COVID-19","volume":"113","author":"Freeman","year":"2022","journal-title":"Can J Public Health"},{"key":"2026081105052652000_13.1.e004082.84","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1186\/s12879-025-11121-z","article-title":"Factors affecting the severity of respiratory infections: a hospital-based cross-sectional study","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Infect Dis"},{"key":"2026081105052652000_13.1.e004082.85","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1004-y","article-title":"Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection-United States, 2005-2008","volume":"15","author":"Garg","year":"2015","journal-title":"BMC Infect Dis"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-004082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:06:23Z","timestamp":1786449983000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-004082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,8,11]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjresp-2025-004082"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-004082","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}